Kuhadiya, Nitesh D <br/><br/>
Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks.  [electronic resource] 

 -  Diabetes care  Jun 2016 
 - 1027-35 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1935-5548 
<br/><br/><label>Standard No.: </label>10.2337/dc15-1136  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Blood Glucose--metabolism<br/>Body Weight<br/>Diabetes Mellitus, Type 1--complications<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Glucagon--metabolism<br/>Humans<br/>Hypoglycemia--chemically induced<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--therapeutic use<br/>Liraglutide--therapeutic use<br/>Male<br/>Middle Aged<br/>Obesity--complications<br/>Overweight--complications<br/>Postprandial Period<br/>Time Factors<br/>Treatment Outcome